文献速递肿瘤 PET/CT神经核医学

术后18F-氟胆碱PET/CT对高级别胶质瘤患者的预后价值:FuMeGA术后PET标准的临床验证

Prognostic Potential of Postoperative 18F-Fluorocholine PET/CT in Patients With High-Grade Glioma. Clinical Validation of FuMeGA Postoperative PET Criteria.
PubMed 文献 · Clin Nucl Med · 2022-04-15

该前瞻性研究纳入47例高级别胶质瘤患者,评估术后18F-氟胆碱PET/CT的预后价值。术后PET/CT与MRI一致性差,MRI切除分级与预后无显著关联。多因素分析中仅年龄和术后PET/CT与无进展生存期和总生存期显著相关,术后PET/CT阳性部位与后续复发部位一致率为81.82%。

要点

  • 术后18F-氟胆碱PET/CT与术后MRI评估的一致性差。
  • 术后MRI切除分级与预后无显著关联。
  • 术后PET/CT阳性部位与后续肿瘤复发部位一致率为81.82%。

核心结论

  • 术后18F-氟胆碱PET/CT在高级别胶质瘤的结局预测上似乎优于术后MRI,在识别最可能的肿瘤复发部位方面表现更优。

研究设计与样本

  • 前瞻性纳入47例高级别胶质瘤患者,共评估51次检查,4例因复发需二次肿瘤切除而接受2次术后18F-氟胆碱PET/CT扫描。

主要发现

  • 随访中42例患者进展,37例死亡。
  • 术后PET/CT与MRI评估的一致性差。
  • MRI切除分级与预后无显著关联。

关键数值与推荐

  • 术后18F-氟胆碱PET/CT采用5点评分系统分类为阴性(完全切除)或阳性(代谢残留肿瘤,不完全切除)。
  • 术后MRI分类为完全切除与不完全切除。
  • 采用Cohen κ评估术后影像技术的一致性。
  • 采用Kaplan-Meier法和Cox回归分析评估影像与无进展生存期和总生存期的关系。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to assess the prognostic performance of postoperative 18F-fluorocholine PET/CT in patients with high-grade glioma (HGG). METHODS: Patients with HGG who underwent preoperative and postoperative 18F-fluorocholine PET/CT were prospectively enrolled in the study. Postoperative MRI was classified as complete versus incomplete resection. Postoperative 18F-fluorocholine PET/CT was classified as negative (complete) or positive for metabolic residual tumor (incomplete resection) using a 5-point score system. The correlation of positive locations on PET/CT with the sites of subsequent tumor recurrence was evaluated. The concordance of postoperative imaging techniques (Cohen κ) and their relation with progression-free survival and overall survival were assessed using Kaplan-Meier method and Cox regression analysis. RESULTS: Fifty-one studies, belonging to 47 patients, were assessed. Four patients underwent 2 postoperative 18F-fluorocholine PET/CT scans as they needed a second tumor resection for recurrence. In the follow-up, 42 patients progressed, and 37 died. Concordance between postoperative PET/CT and MRI assessment was poor. Resection grade on MRI did not show any significant association with prognosis. In multivariate analysis, only age and postoperative PET/CT showed significant association with progression-free survival (hazard ratio [HR], 1.03 [1.01-1.06, P = 0.006] and 1.88 [0.96-3.71, P = 0.067], respectively) and overall survival (HR, 1.04 [1.01-1.07, P = 0.004] and 2.63 [1.22-5.68, P = 0.014], respectively). Postoperative positive 18F-fluorocholine PET/CT locations correlated with the sites of subsequent tumor recurrence in 81.82% of cases. CONCLUSION: Postoperative 18F-fluorocholine PET/CT seems superior to postoperative MRI in the outcome prediction of patients with HGG, outperforming it in the identification of the most probable location of tumor recurrence.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. García Vicente AM, Pena Pardo FJ, Amo-Salas M, et al. Prognostic Potential of Postoperative 18F-Fluorocholine PET/CT in Patients With High-Grade Glioma. Clinical Validation of FuMeGA Postoperative PET Criteria. Clin Nucl Med. 2022. PMID: 35426853. doi:10.1097/RLU.0000000000004127

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。